REQUEST A DEMO
Total
USD $0.00
Search more companies

Sempervivum Bt. (Hungary)

Main Activities: Pharmacies and Drug Stores
Full name: SEMPERVIVUM Gyogyszereszeti Bt. Profile Updated: August 16, 2023
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English & Hungarian Download a sample report

Sempervivum Bt. is an enterprise in Hungary, with the main office in Lovasbereny. The company operates in the Pharmacies and Drug Stores sector. It was first established on May 21, 1996. Sempervivum Bt. currently employs 3 (2023) people. From the latest financial highlights, Sempervivum Bt. reported a net sales revenue increase of 20.7% in 2022. During that time, Sempervivum Bt.’s total assets grew by 62.52%. In 2022, Sempervivum Bt.’s net profit margin increased by 1.19%.

Headquarters
Vaczi M. u. 8/D.
Lovasbereny; Fejer; Postal Code: 8093

Contact Details: Purchase the Sempervivum Bt. report to view the information.

Basic Information
Total Employees:
Purchase the Sempervivum Bt. report to view the information.
Outstanding Shares:
Purchase the Sempervivum Bt. report to view the information.
Registered Capital:
Purchase the Sempervivum Bt. report to view the information.
Incorporation Date:
May 21, 1996
Key Executives
Purchase this report to view the information.
Managing Director
Ownership Details
Purchase this report to view the information.
Purchase this report to view the information.
Purchase this report to view the information.
Company Performance
Financial values in the chart are available after Sempervivum Bt. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency HUF. Absolute financial data is included in the purchased report.
Net sales revenue
20.7%
Total operating revenue
20.02%
Operating profit (EBIT)
36.75%
EBITDA
32.81%
Net Profit (Loss) for the Period
39.36%
Total assets
62.52%
Total equity
32.15%
Operating Profit Margin (ROS)
1.03%
Net Profit Margin
1.19%
Return on Equity (ROE)
2.31%
Quick Ratio
-0.12%
Cash Ratio
0.01%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?